Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth

Sanjay Saw1, Alison Aiken1, Hui Fang1

  • 1Princess Margaret Cancer Centre/Ontario Cancer Institute, University Health Network, Toronto, Canada.

Insights

Tissue inhibitors of metalloprotease (TIMPs) are vital for postnatal bone growth. TIMP deficiency causes growth plate closure, limb shortening, and skeletal deformities in mice.

Area of Science:

  • Biochemistry
  • Genetics
  • Developmental Biology

Background:

  • Regulated growth plate activity is crucial for bone development and stature.
  • The molecular mechanisms governing epiphyseal fusion remain incompletely understood.

Purpose of the Study:

  • To investigate the role of the tissue inhibitors of metalloprotease (TIMP) gene family in postnatal bone growth.
  • To elucidate the regulatory pathways involving TIMPs in chondrocyte maturation and skeletal development.

Main Methods:

  • Generation and analysis of whole-body quadruple-knockout mice lacking all four TIMPs.
  • Utilizing knock-in mouse models with MMP-resistant or ADAMTS-resistant aggrecans to assess TIMP function.
  • Examining growth plate activity, epiphyseal fusion, and skeletal morphology.

Main Results:

  • TIMP deficiency leads to premature growth plate closure, limb shortening, epiphyseal distortion, and chondrodysplasia.
  • A novel nexus involving TIMPs, FGF-2, and IHH was identified, where TIMPs regulate FGF-2 release and IHH expression.
  • TIMPs are essential negative regulators of chondrocyte maturation and growth plate integrity.
  • Redundancy in metalloprotease inhibitor function during development was observed.

Conclusions:

  • Tissue inhibitors of metalloprotease (TIMPs) are critical regulators of chondrocyte maturation, growth plate integrity, and skeletal proportionality.
  • The TIMP/FGF-2/IHH pathway is a key determinant of bone lengthening.
  • Metalloprotease inhibitors play essential roles in both embryonic and postnatal skeletal development.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

3.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.7K
Methods for Controlling Microbial Growth01:29

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
1.6K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding01:22

Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding

When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
602
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K